Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

The Role of Medical Device Consultants in Accelerating Innovation in Riverside County

May 31, 2025

Introduction to Medical Device Consultants

In the rapidly evolving landscape of healthcare, innovation is key to meeting the growing demands for better patient outcomes and more efficient treatment modalities. Medical device consultants play a crucial role in this process, especially in areas like Riverside County where the healthcare industry is both a major economic driver and a critical service sector.

These professionals provide expertise that helps medical device companies navigate the complexities of product development, regulatory compliance, and market entry. Their contributions can significantly accelerate the pace of innovation, ensuring that groundbreaking technologies reach patients faster.

medical device consultant

The Expertise of Medical Device Consultants

Understanding Regulatory Compliance

One of the primary roles of medical device consultants is to guide companies through the intricate web of regulatory requirements. The healthcare industry is heavily regulated to ensure patient safety and product efficacy. Consultants are well-versed in the standards set by bodies like the FDA and EMA, helping companies prepare the necessary documentation and submissions.

By leveraging their knowledge, consultants can streamline the approval process, reducing delays and avoiding costly mistakes. This expertise is invaluable in Riverside County, where many startups and established firms are focused on bringing innovative products to market.

Facilitating Product Development

Medical device consultants also bring a wealth of knowledge in product development. From ideation to prototyping, they offer insights that can enhance design, functionality, and usability. Their input ensures that devices not only meet regulatory standards but also serve the practical needs of healthcare professionals and patients.

product development

Accelerating Innovation in Riverside County

Supporting Startups and Established Companies

Riverside County is home to a dynamic ecosystem of healthcare innovators, ranging from startups to established companies. Medical device consultants provide critical support across this spectrum. For startups, they offer guidance on securing funding, navigating early-stage challenges, and building strategic partnerships. For larger firms, consultants can refine product lines and introduce cutting-edge technologies.

This dual support accelerates innovation by ensuring that companies can focus on their core competencies while relying on expert advice for complex issues.

Enhancing Market Readiness

Getting a medical device to market is a multifaceted process that involves rigorous testing, compliance checks, and strategic marketing. Consultants assist in crafting effective go-to-market strategies that align with regulatory requirements and market demands. They help companies identify target markets, assess competition, and position their products for success.

market strategy

The Future of Medical Device Innovation

As Riverside County continues to grow as a hub for healthcare innovation, the role of medical device consultants will become even more pivotal. They will continue to bridge the gap between technology and practical application, ensuring that new devices meet the highest standards of safety and efficacy.

In a future where personalized medicine and advanced diagnostics are becoming increasingly important, their expertise will be crucial in translating scientific advances into tangible solutions that improve patient care.

Ultimately, medical device consultants are more than just advisors; they are enablers of innovation. Their contributions help drive the industry forward, ensuring that Riverside County remains at the forefront of medical advancements.